Please assess the completion status of the following clinical trial:

Trial Title: Goal Directed Haemodynamic Treatment for Patients With Proximal Femoral Fracture

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients (men and women) age ≥ 70 years~* Patients´ scheduled for operation of proximal femoral fracture during office hours~* Patient who have a witnessed or written informed consent~Exclusion Criteria:~Any of the following is regarded as a criterion for exclusion from the study:~* Concomitant medication with Lithium~* Known allergy (or hypersensitivity) to Lithium, or components of the medical device~* Weight ≤ 40 kg~* Other conditions or symptoms preventing the subject from entering the study, according to investigators judgment~* Life expectancy less than 6 months and/or pathological fractures~* Not possible to insert arterial line.

- Gender: ALL
- Minimum Age: 70 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Routine fluid treatment (Type: ACTIVE_COMPARATOR): Buffered Glucose 25 mg/ml 1ml/kg/h Ringer's Acetate 2 ml/kg/h and additionally as needed Voluven at the attending anaesthetist's discretion Phenylephrine 50 μg for correction of hypotension
- Goal directed haemodynamic treatment (Type: EXPERIMENTAL): Goal directed haemodynamic treatment Dobutamine 0.2-10 μg/kg/min Buffered Glucose 25 mg/ml 1ml/kg/h Ringer's Acetate 2 ml/kg/h Voluven 3 ml/kg as fluid challenge at the attending anaesthetist's discretion Phenylephrine 50 μg for correction of hypotension

Based on this trial design, predict the completion outcome and termination type (if applicable).